Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Efficacy of Automated Tuina and Acupuncture for Treating Chronic Lower Back Pain

15 novembre 2026 aggiornato da: Linda Zhong, Nanyang Technological University

Efficacy of Automated Tuina and Acupuncture for Treating Chronic Lower Back Pain: a Randomized Controlled Study

The goal of this clinical trial is to learn if adding automated robotic Tuina to acupuncture yields a better outcome than acupuncture alone in treating adults with chronic nonspecific low back pain. It will also learn about the safety of the automated robotic Tuina. The main questions it aims to answer are:

Does robotic Tuina and acupuncture reduces score of Visual Analogue Scale (VAS) more than acupuncture alone? Does it improve the sleep, quality of life, pain related impact of participants? Researchers will compare automated robotic Tuina and acupuncture to acupuncture alone if the combination works better to treat chronic nonspecific low back pain.

Participants will:

Receive weekly treatment of either automated robotic Tuina and acupuncture or acupuncture only for 6 sessions over 8 weeks.

Visit the clinic weekly for interventions and test. Wear a sleep tracker ring on the night before and night of treatment to sleep.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Chronic nonspecific low back pain is a common condition that can affect daily activities and quality of life. Tuina is a traditional Chinese medicine manual therapy that may help relieve pain and improve function. Automated robotic Tuina may offer a more standardized approach to delivering this treatment.

This randomized controlled study aims to evaluate whether adding automated robotic Tuina to acupuncture provides additional benefits for adults with chronic nonspecific low back pain, compared with acupuncture alone.

A total of 56 participants aged 21 to 70 years are planned for recruitment across three study sites in Singapore. Participants will be randomly assigned in a 1:1 ratio to receive either acupuncture alone or acupuncture combined with automated robotic Tuina.

The primary outcome is low back pain intensity measured using a visual analogue scale (VAS). Secondary outcomes include physical disability, pain-related interference, quality of life, sleep-related measures and acceptance of robotic Tuina. Adverse events will also be monitored throughout the study.

The findings may help clarify the additional clinical benefit and safety of automated robotic Tuina when used alongside acupuncture for chronic nonspecific low back pain.

Tipo di studio

Interventistico

Iscrizione (Stimato)

56

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

      • Singapore, Singapore, 229469
        • Reclutamento
        • Novahealth TCM Clinic
        • Contatto:
          • Chin Ee Ho
          • Numero di telefono: +65 84130628
      • Singapore, Singapore, 637551

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 21 anni a 70 anni (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Adults aged 21 to 70 years.
  • At least one primary care visit for back pain within the past 3 to 12 months at either a Chinese medicine or Western medicine clinic.
  • Non-specific, uncomplicated low back pain, as specified in the study protocol.
  • Able to communicate and write in English and/or Chinese.

Exclusion Criteria:

  • Previous acupuncture for back pain within the past 3 months.
  • Low back pain lasting less than 3 months.
  • Mild symptoms, defined in the protocol as a score below 5 on a 0 to 10 pain bothersomeness scale.
  • Specific diseases or pathologies identified as the cause of back pain, including the conditions listed in the study protocol.
  • Previous vertebral column or back surgery.
  • Disabling chronic conditions that may confound treatment effects or interpretation of the data.
  • Contraindications to acupuncture or situations in which its safety has not been confirmed, including clotting disorders, anticoagulant therapy, a cardiac pacemaker, pregnancy or seizure disorder.
  • Deemed unfit for acupuncture and/or robotic Tuina by the treating Chinese medicine physician because of the participant's current medical condition.
  • Current use of long-term medication for pain management and relief, as specified in the study protocol.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Acupuncture Plus Automated Robotic Tuina

Standard acupuncture treatment followed by Automated Robotic Tuina

Participants receive 30 minute standard acupuncture and automated robotic Tuina using the EMMA device, according to the study's standardized operating procedures. Robotic Tuina is applied to the lumbosacral region, hips and lower limbs. The protocol describes an approximately 30-minute robotic Tuina treatment, with the applied force adjusted according to participant feedback within the specified range.

Comparatore attivo: Acupuncture alone

Standard acupuncture

Participants receive acupuncture according to the study's standardized treatment protocol. The protocol describes needle retention for 30 minutes and specifies the acupuncture points and procedures to be used.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change from baseline in pain intensity. Visual analogue scale.
Lasso di tempo: At baseline, at 8 weeks

A 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain

At baseline, at 8 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change from baseline in Roland Morris Disability Questionnaire (RMDQ).
Lasso di tempo: At baseline and at 8 weeks

This is a self-reported questionnaire consisting in 24 items reflecting limitations in different activities of daily living attributed to low back pain including walking, vending over, sitting, lying down, dressing, sleeping, self-care and daily activities.

At baseline and at 8 weeks
Change from baseline in Brief Pain Inventory (BPI)
Lasso di tempo: At baseline and at 8 weeks

Pain interference was evaluated using the Pain Interference subscale of the Brief Pain Inventory (BPI). The subscale consists of 7 items assessing how much pain disrupts dimensions of daily living. Each item is scored on a 0 to 10 numeric rating scale. The overall score is calculated as the mean of the 7 items, yielding a final score ranging from a minimum of 0 to a maximum of 10. A higher score indicates a worse outcome (greater pain interference with daily functioning).

At baseline and at 8 weeks
Change from baseline in WHO-QOL (Brief)
Lasso di tempo: At baseline and at 8 weeks

Quality of life was evaluated using the World Health Organization Quality of Life-BREF (WHOQOL-BREF). The scale comprises 26 items assessing 4 domains: Physical Health (7 items), Psychological (6 items), Social Relationships (3 items), and Environment (8 items). Domain scores are calculated by summing the respective items and converting them to a transformed scale. For each domain, scores range from a minimum of 0 to a maximum of 100, where a higher score indicates a better outcome (higher quality of life)

At baseline and at 8 weeks
Change in objective sleep parameters via wearable smart ring
Lasso di tempo: At baseline throughout the 8 weeks, to be tracked the night before and after treatment session.

Assessed using Leadtek smart ring worn on the finger. Evaluated parameters include sleep time, overnight heart rate variability and sleep quality from baseline to week 8

At baseline throughout the 8 weeks, to be tracked the night before and after treatment session.
Change in Technology Acceptance Model (TAM) questionnaire from baseline
Lasso di tempo: At baseline and at 8 weeks

Participant acceptance of automated robotic Tuina, will be measured at baseline and after completion of study covering domains including perceieved usefulness, attitude and behavioural intentions. A 7-point Likert scale was used to measure TAM constructs, where 1 indicated 'strongly disagree' and 7 indicated ' strongly agree'. A higher score reflects better perception of and attitutude towards the technology.

At baseline and at 8 weeks
Incidence of Treatment-Emergent Adverse Events [Safety]
Lasso di tempo: From start of treatment to end of treatment at week 8

Incidence and nature of adverse events during the study.

From start of treatment to end of treatment at week 8

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Linda Zhong, Associate Professor, Nanyang Technological University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 gennaio 2025

Completamento primario (Stimato)

30 dicembre 2027

Completamento dello studio (Stimato)

30 dicembre 2027

Date di iscrizione allo studio

Primo inviato

29 ottobre 2026

Primo inviato che soddisfa i criteri di controllo qualità

15 novembre 2026

Primo Inserito (Effettivo)

18 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

15 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • IRB-2023-1071

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data will not be made available to external researchers. Participant-level data contain confidential health information and will be managed in accordance with the approved study protocol, informed consent requirements, institutional policies and applicable data-protection requirements. Study findings will be disseminated through appropriate scientific publications and other research outputs.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .